EZZ Life Science Holdings Limited (EZZ.AX)
AUD 1.45
(-0.68%)
AUD 1.45
(-0.68%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 4.22 Million AUD | 38.28% |
| 2023 | 3.05 Million AUD | 6.27% |
| 2022 | 2.87 Million AUD | 49.05% |
| 2021 | 1.93 Million AUD | -48.86% |
| 2020 | 3.77 Million AUD | 80.61% |
| 2019 | 2.09 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 4.99 Million AUD | 73.7% |
| 2024 FY | 4.22 Million AUD | 38.28% |
| 2024 Q4 | 4.22 Million AUD | 0.0% |
| 2024 Q2 | 4.99 Million AUD | 0.0% |
| 2023 Q1 | 2.32 Million AUD | -19.38% |
| 2023 FY | 3.05 Million AUD | 6.27% |
| 2023 Q4 | 2.87 Million AUD | -5.9% |
| 2023 Q3 | 3.05 Million AUD | 30.19% |
| 2023 Q2 | 2.34 Million AUD | 1.25% |
| 2022 Q1 | 1.7 Million AUD | -11.77% |
| 2022 FY | 2.87 Million AUD | 49.05% |
| 2022 Q4 | 2.87 Million AUD | 2.17% |
| 2022 Q3 | 2.81 Million AUD | 64.14% |
| 2022 Q2 | 1.71 Million AUD | 0.74% |
| 2021 Q1 | 2.69 Million AUD | -28.71% |
| 2021 FY | 1.93 Million AUD | -48.86% |
| 2021 Q3 | 1.92 Million AUD | -28.3% |
| 2021 Q4 | 1.93 Million AUD | 0.07% |
| 2021 Q2 | 2.69 Million AUD | 0.0% |
| 2020 Q4 | 3.77 Million AUD | 0.0% |
| 2020 FY | 3.77 Million AUD | 80.61% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 Q3 | 3.77 Million AUD | 0.0% |
| 2019 FY | 2.09 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | -19.381% |
| Acrux Limited | 5.68 Million AUD | 25.635% |
| Actinogen Medical Limited | 1.61 Million AUD | -161.807% |
| AnteoTech Limited | 4.07 Million AUD | -3.776% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -74.274% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -105.634% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -1278.25% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 22.053% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -23.414% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -349.173% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -1047.833% |
| Biome Australia Limited | 5.37 Million AUD | 21.293% |
| Biotron Limited | 737.5 Thousand AUD | -473.437% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -13.319% |
| BTC Health Limited | 203.94 Thousand AUD | -1973.639% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 66.968% |
| CSL Limited | 27.88 Billion AUD | 99.985% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 49.241% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 84.956% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -261.14% |
| Dimerix Limited | 13.89 Million AUD | 69.559% |
| Hexima Limited | 248.67 Thousand AUD | -1600.706% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -304.461% |
| Immuron Limited | 2.84 Million AUD | -48.886% |
| Immutep Limited | 10.97 Million AUD | 61.482% |
| Imugene Limited | 33.14 Million AUD | 87.24% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -879.808% |
| Memphasys Limited | 5.59 Million AUD | 24.377% |
| Nanollose Limited | 465.64 Thousand AUD | -808.238% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 90.11% |
| Noxopharm Limited | 1.28 Million AUD | -228.193% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -4835.804% |
| Nyrada Inc. | 855.63 Thousand AUD | -394.271% |
| Orthocell Limited | 22.08 Million AUD | 80.849% |
| PharmAust Limited | 896.6 Thousand AUD | -371.683% |
| Patrys Limited | 691.36 Thousand AUD | -511.709% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -17.989% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -160.107% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -81.855% |
| PYC Therapeutics Limited | 10.18 Million AUD | 58.473% |
| Race Oncology Limited | 1.91 Million AUD | -120.679% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 90.535% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 73.391% |
| Starpharma Holdings Limited | 8.69 Million AUD | 51.378% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 98.304% |
| Tissue Repair Ltd | 1.35 Million AUD | -213.06% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 54.8% |